EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel Small Molecule Enhances Stable Dopamine Delivery to the Brain in Models of Parkinson’s Disease

Xiaoguang Liu, Michaeline L Hebron, Max Stevenson, Charbel Moussa iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26094251 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Xiaoguang Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Translational Neurotherapeutics Program, Laboratory for Dementia and Parkinsonism, Department of Neurology, Georgetown University Medical Center, Was…. Hauptthemen laut MEDLINE: Dopamine, Parkinson Disease, Brain. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Skybio LLC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Levodopa is the gold standard symptomatic treatment for Parkinson’s disease. Disease progression due to alpha-synuclein accumulation, brain inflammation, and the loss of dopamine neurons, as well as motor fluctuations, due to variations in levodopa plasma levels, remain a significant problem for Parkinson’s patients. Developing a therapeutic option that can simultaneously reduce the neuropathology associated with alpha-synuclein aggregation, attenuate oxidative stress and inflammation, and overcome variations in levodopa plasma levels is an unmet need to treat Parkinson’s disease. We determined the pharmacokinetics and pharmacodynamics of a small molecule, dubbed Pegasus, that conjugates dopamine with a nonantibiotic doxycycline derivative via a molecular linker. Mice harboring the human A53T mutation of alpha-synuclein or treated with MPTP were injected once daily with 50 mg/kg Pegasus for 2 weeks and assessed for motor, behavioral, and cognitive effects, followed by biochemical and histochemical analysis. Pegasus is a poor brain penetrant but it was metabolized to stable dopamine and tetracycline derivatives, and abundant plasma and brain levels of these metabolites were detected. Pegasus reduced soluble and insoluble alpha-synuclein levels, protected dopamine-producing neurons, and reduced astrocytic activation in A53T mice. Mice treated with Pegasus exhibited motor improvement (6.5 h) and reduction in anxiety-like behavior. Rotarod and grip strength improved in MPTP-treated mice when mice were treated with Pegasus or levodopa. Pegasus may be a multi-modal therapeutic option that can deliver stable dopamine into the CNS and reduce misfolded alpha-synuclein, activate dopamine receptors, and attenuate variations in dopamine levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DopamineParkinson DiseaseBrainAnimalsMicealpha-SynucleinDisease Models, AnimalHumansMaleMice, Inbred C57BLLevodopaDoxycyclineDopaminergic Neurons

Stichwörter der Autor:innen

Parkinson’s diseasePegasusdopaminelevodopatetracycline

Substanzen

Dopaminealpha-SynucleinLevodopaDoxycycline

Autor:innen und Institutionen

  • Translational Neurotherapeutics Program, Laboratory for Dementia and Parkinsonism, Department of Neurology, Georgetown University Medical Center, Washington, DC 20007, USA.

ORCID-Profile: Charbel Moussa

Förderung

  • Skybio LLC

Zitieren

APA

Liu, X., Hebron, M. L., Stevenson, M., & Moussa, C. (2025). A Novel Small Molecule Enhances Stable Dopamine Delivery to the Brain in Models of Parkinson’s Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26094251

Vancouver

Liu X, Hebron ML, Stevenson M, Moussa C. A Novel Small Molecule Enhances Stable Dopamine Delivery to the Brain in Models of Parkinson’s Disease. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26094251

BibTeX
@article{Liu2025,
  author = {Liu, Xiaoguang and Hebron, Michaeline L and Stevenson, Max and Moussa, Charbel},
  title = {A Novel Small Molecule Enhances Stable Dopamine Delivery to the Brain in Models of Parkinson’s Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26094251}
}
Kostenlos starten →